Log In
BCIQ
Print this Print this
 

Cyanokit, hydoxocobalamin

  Manage Alerts
Collapse Summary General Information
Company Merck KGaA
DescriptionPrecursor of vitamin B12
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationPoisoning
Indication DetailsTreat cyanide poisoning
Regulatory Designation U.S. - Orphan Drug (Treat cyanide poisoning)
PartnerPfizer Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
Get a free BioCentury trial today